Despite advances in surgical techniques, perioperative therapies and postoperative management, outcomes for patients with bladder cancer have largely remained unchanged. Current management of bladder cancer still relies on pathologic staging that does not always reflect the risk for an individual patient. Studies assessing molecular alterations in individual tumors are offering insights into the myriad of cellular pathways that are deregulated in bladder tumorigenesis and progression. Alterations in pathways involved in cell-cycle regulation, apoptosis, cell signaling, angiogenesis and tumor-cell invasion have been shown to influence disease behavior. High-throughput assays are now allowing multiplexed assessment of biomarker alterations, t...
Urothelial carcinoma of the bladder comprises two long-recognized disease entities with distinct mol...
During the 2019 International Society of Urological Pathology Consultation Conference on Molecular P...
© 2015 Dr. Nikhil SapreMuch remains to be elucidated regarding the molecular mechanisms driving urot...
Bladder cancer is one of the most prevalent cancers worldwide. Unfortunately, there have been few ad...
Several molecular and genetic studies have provided new perspectives on the histologic classificatio...
Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder can...
Muscle-invasive bladder cancer is a heterogeneous disease with different clinical phenotypes. Histom...
Transitional cell carcinoma of the bladder is a common malignancy with an estimated 549 393 new case...
Bladder cancer is one of the most common malignancies world-wide, and in Sweden approximately 3000 c...
Bladder cancer (BC) is a heterogeneous disease encompassing distinct biologic features that lead to ...
In the last decades, only few improvements have been made in the comprehension of bladder cancer tum...
Urothelial carcinoma of the bladder is a common malignancy causing an estimated 150,000 deaths per y...
Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and cl...
The current personalized oncology era has witnessed significant efforts to integrate clinical, patho...
Bladder cancer is associated with high recurrence and mortality rates. These tumors show vast hetero...
Urothelial carcinoma of the bladder comprises two long-recognized disease entities with distinct mol...
During the 2019 International Society of Urological Pathology Consultation Conference on Molecular P...
© 2015 Dr. Nikhil SapreMuch remains to be elucidated regarding the molecular mechanisms driving urot...
Bladder cancer is one of the most prevalent cancers worldwide. Unfortunately, there have been few ad...
Several molecular and genetic studies have provided new perspectives on the histologic classificatio...
Bladder cancer is a global health issue with sex differences in incidence and prognosis. Bladder can...
Muscle-invasive bladder cancer is a heterogeneous disease with different clinical phenotypes. Histom...
Transitional cell carcinoma of the bladder is a common malignancy with an estimated 549 393 new case...
Bladder cancer is one of the most common malignancies world-wide, and in Sweden approximately 3000 c...
Bladder cancer (BC) is a heterogeneous disease encompassing distinct biologic features that lead to ...
In the last decades, only few improvements have been made in the comprehension of bladder cancer tum...
Urothelial carcinoma of the bladder is a common malignancy causing an estimated 150,000 deaths per y...
Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and cl...
The current personalized oncology era has witnessed significant efforts to integrate clinical, patho...
Bladder cancer is associated with high recurrence and mortality rates. These tumors show vast hetero...
Urothelial carcinoma of the bladder comprises two long-recognized disease entities with distinct mol...
During the 2019 International Society of Urological Pathology Consultation Conference on Molecular P...
© 2015 Dr. Nikhil SapreMuch remains to be elucidated regarding the molecular mechanisms driving urot...